| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.92B | 70.03B | 67.29B | 62.13B | 52.89B | 41.85B |
| Gross Profit | 23.13B | 24.04B | 23.73B | 21.80B | 17.83B | 13.90B |
| EBITDA | 8.97B | 9.30B | 9.50B | 8.30B | 5.83B | 3.37B |
| Net Income | 5.35B | 5.88B | 6.00B | 4.97B | 3.33B | 1.91B |
Balance Sheet | ||||||
| Total Assets | 73.38B | 82.92B | 75.85B | 78.23B | 67.18B | 61.92B |
| Cash, Cash Equivalents and Short-Term Investments | 13.56B | 14.70B | 12.77B | 16.80B | 14.30B | 16.16B |
| Total Debt | 73.00M | 611.00M | 1.05B | 5.30B | 712.00M | 958.00M |
| Total Liabilities | 17.93B | 21.52B | 19.15B | 25.52B | 20.00B | 16.33B |
| Stockholders Equity | 55.45B | 61.40B | 56.69B | 52.72B | 46.95B | 45.38B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.65B | 2.26B | 498.00M | 947.00M | 1.34B |
| Operating Cash Flow | 0.00 | 5.05B | 4.45B | 2.74B | 1.92B | 2.02B |
| Investing Cash Flow | 0.00 | -273.00M | -1.15B | -3.78B | -1.06B | -932.00M |
| Financing Cash Flow | 0.00 | -3.88B | -7.25B | 2.80B | -2.90B | -2.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥73.71B | 11.00 | ― | 3.12% | 4.08% | -1.67% | |
81 Outperform | ¥15.12B | 10.05 | ― | 5.39% | 2.47% | -6.77% | |
81 Outperform | ¥159.12B | 14.32 | ― | 3.23% | 5.32% | -3.12% | |
79 Outperform | ¥1.03T | 21.67 | 11.99% | 0.65% | 8.38% | 8.43% | |
73 Outperform | ¥21.26B | 8.02 | ― | 2.93% | 6.08% | 10.11% | |
69 Neutral | ¥26.81B | 12.06 | ― | 2.89% | 7.91% | 2.84% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |